Literature DB >> 12890562

Murine granulosa cell morphology and function are regulated by a synthetic Arg-Gly-Asp matrix.

Pamela K Kreeger1, Teresa K Woodruff, Lonnie D Shea.   

Abstract

Extracellular matrix (ECM) proteins are established regulators of granulosa cell survival, morphology, and differentiation. In this study, the roles of ECM adhesion peptide density on murine granulosa cell adhesion, morphology, and steroid secretion were probed using synthetic matrices. The synthetic matrix was fabricated from the polysaccharide alginate, which does not inherently support cell adhesion but can be modified with controlled densities of adhesion peptides (10(-4) to 2 x 10(-1) ng/cm(2)). GRM02, a murine granulosa cell line, and primary murine granulosa cells were cultured on alginate matrices modified by coupling of synthetic peptide sequences containing the Arg-Gly-Asp motif common to ECM proteins. Cells cultured on these peptide-modified surfaces (0.02, 0.2 ng/cm(2)) attached and spread, with morphologies specific to the peptide identity and density. Additionally, progesterone and estradiol secretion was a function of peptide density, with up to threefold increases compared to controls. These results indicate that the density and identity of adhesion peptides regulate granulosa cell function. This system provides a mechanism to examine the granulosa cell-ECM interactions that occur during follicle maturation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890562     DOI: 10.1016/s0303-7207(03)00209-0

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  22 in total

1.  A new hypothesis regarding ovarian follicle development: ovarian rigidity as a regulator of selection and health.

Authors:  Teresa K Woodruff; Lonnie D Shea
Journal:  J Assist Reprod Genet       Date:  2010-09-25       Impact factor: 3.412

2.  The in vitro regulation of ovarian follicle development using alginate-extracellular matrix gels.

Authors:  Pamela K Kreeger; Jason W Deck; Teresa K Woodruff; Lonnie D Shea
Journal:  Biomaterials       Date:  2005-08-01       Impact factor: 12.479

Review 3.  The structures that underlie normal reproductive function.

Authors:  Thomas F Lerch; Min Xu; Theodore S Jardetzky; Kelly E Mayo; Ishwar Radhakrishnan; Ralph Kazer; Lonnie D Shea; Teresa K Woodruff
Journal:  Mol Cell Endocrinol       Date:  2006-11-30       Impact factor: 4.102

Review 4.  Extracellular matrix functions in follicle maturation.

Authors:  Courtney B Berkholtz; Lonnie D Shea; Teresa K Woodruff
Journal:  Semin Reprod Med       Date:  2006-09       Impact factor: 1.303

Review 5.  The role of the extracellular matrix in ovarian follicle development.

Authors:  Teresa K Woodruff; Lonnie D Shea
Journal:  Reprod Sci       Date:  2007-12       Impact factor: 3.060

6.  Bioengineering Strategies to Treat Female Infertility.

Authors:  Che-Ying Kuo; Hannah Baker; Melissa H Fries; James J Yoo; Peter C W Kim; John P Fisher
Journal:  Tissue Eng Part B Rev       Date:  2017-02-03       Impact factor: 6.389

Review 7.  Bioengineering the ovarian follicle microenvironment.

Authors:  Lonnie D Shea; Teresa K Woodruff; Ariella Shikanov
Journal:  Annu Rev Biomed Eng       Date:  2014-05-14       Impact factor: 9.590

Review 8.  Microfluidic Systems for Assisted Reproductive Technologies: Advantages and Potential Applications.

Authors:  Russel C Sequeira; Tracy Criswell; Anthony Atala; James J Yoo
Journal:  Tissue Eng Regen Med       Date:  2020-11-25       Impact factor: 4.169

Review 9.  Lessons from bioengineering the ovarian follicle: a personal perspective.

Authors:  Teresa K Woodruff
Journal:  Reproduction       Date:  2019-12       Impact factor: 3.906

Review 10.  Three-dimensional in vitro follicle growth: overview of culture models, biomaterials, design parameters and future directions.

Authors:  Nina Desai; Anastasia Alex; Faten AbdelHafez; Anthony Calabro; James Goldfarb; Aaron Fleischman; Tommaso Falcone
Journal:  Reprod Biol Endocrinol       Date:  2010-10-14       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.